MA29015B1 - SPECIFIC BINDING AGENTS OF ANGIOPOIETIN-2 - Google Patents

SPECIFIC BINDING AGENTS OF ANGIOPOIETIN-2

Info

Publication number: MA29015B1
Authority: MA; Morocco
Prior art keywords: angiopoietin; specific binding; binding agents; agents; specific
Prior art date: 2004-10-19

Application number

MA29892A

Other languages

French (fr)

Inventor

Jonathon Daniel Oliner

Kevin Graham

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-19

Filing date

2007-05-11

Publication date

2007-11-01

2004-11-04 Priority claimed from US10/982,440 external-priority patent/US7658924B2/en

2007-05-11 Application filed by Amgen Inc filed Critical Amgen Inc

2007-11-01 Publication of MA29015B1 publication Critical patent/MA29015B1/en

Links

MA29892A 2004-10-19 2007-05-11 SPECIFIC BINDING AGENTS OF ANGIOPOIETIN-2 MA29015B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62016104P	2004-10-19	2004-10-19
US10/982,440 US7658924B2 (en)	2001-10-11	2004-11-04	Angiopoietin-2 specific binding agents

Publications (1)

Publication Number	Publication Date
MA29015B1 true MA29015B1 (en)	2007-11-01

Family

ID=39608222

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29892A MA29015B1 (en)	2004-10-19	2007-05-11	SPECIFIC BINDING AGENTS OF ANGIOPOIETIN-2

Country Status (10)

Country	Link
JP (2)	JP2008520188A (en)
CN (1)	CN101495513B (en)
BR (1)	BRPI0518209A (en)
EA (1)	EA011866B1 (en)
IL (1)	IL182279A0 (en)
MA (1)	MA29015B1 (en)
MX (1)	MX2007004247A (en)
RU (2)	RU2404992C2 (en)
SG (1)	SG156668A1 (en)
ZA (1)	ZA200704020B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2404992C2 (en) *	2004-10-19	2010-11-27	Эмджен Инк.	Angiopoietin-2-specific coupling agents
JO3182B1 (en) *	2009-07-29	2018-03-08	Regeneron Pharma	High Affinity Human Antibodies to Human Angiopoietin-2
EA022546B1 (en) *	2011-09-28	2016-01-29	Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук	Method for inhibiting growth of ehrlich carcinoma in laboratory animal
ES2619707T3 (en) *	2011-09-30	2017-06-26	Dana-Farber Cancer Institute, Inc.	Therapeutic peptides
KR102063028B1 (en) *	2012-01-23	2020-01-07	리제너론 파아마슈티컬스, 인크.	Stabilized formulations containing anti-ang2 antibodies
WO2014100834A1 (en) *	2012-12-21	2014-06-26	The Regents Of The University Of California	Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
SG11201509278XA (en)	2013-05-14	2015-12-30	Eisai R&D Man Co Ltd	Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
AR100270A1 (en) *	2014-05-19	2016-09-21	Lilly Co Eli	ANTIBODIES ANG2
PL3524595T3 (en)	2014-08-28	2022-10-31	Eisai R&D Management Co., Ltd.	High-purity quinoline derivative and method for manufacturing same
SI3263106T1 (en)	2015-02-25	2024-02-29	Eisai R&D Management Co., Ltd.	Method for suppressing bitterness of quinoline derivative
KR20240064733A (en)	2015-03-04	2024-05-13	머크 샤프 앤드 돔 코포레이션	Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
MX2017015896A (en)	2015-06-16	2018-08-09	Eisai R&D Man Co Ltd	Anticancer agent.
CN106075448A (en) *	2016-07-25	2016-11-09	广州道瑞医药科技有限公司	ANGPT2 inhibitor is used for treating the application in angiomatous medicine in preparation
CN106512006A (en) *	2016-07-25	2017-03-22	广州道瑞医药科技有限公司	Application of ANGPT2 secretion inhibitor to preparation of medicine for treating hemangiomas
CN109096368B (en) *	2018-09-30	2021-07-20	华南理工大学	Polypeptide with antioxidant and liver protecting activities, gene for encoding polypeptide, preparation method and application thereof
AU2020227580A1 (en) *	2019-02-25	2021-09-30	Pharmabcine Inc.	Anti-Ang2 antibody and use thereof
CN112126671B (en) *	2020-08-18	2021-08-31	中山大学附属第五医院	Application of streptococcus agalactiae streptococcus agalactiae in treating endometriosis
CN116265487A (en) *	2021-12-16	2023-06-20	三优生物医药(上海)有限公司	anti-ANG 2-VEGF bispecific antibodies and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE241380T1 (en) *	1999-03-26	2003-06-15	Regeneron Pharma	MODULATION OF VASCULAR PERMEABILITY USING TIE2 RECEPTOR ACTIVATORS
US7521053B2 (en) *	2001-10-11	2009-04-21	Amgen Inc.	Angiopoietin-2 specific binding agents
US7205275B2 (en) *	2001-10-11	2007-04-17	Amgen Inc.	Methods of treatment using specific binding agents of human angiopoietin-2
ES2444951T5 (en) *	2001-10-12	2022-06-28	Aquestive Therapeutics Inc	Uniform films for a fast-dissolving dosage form incorporating taste-masking compositions
RU2404992C2 (en) *	2004-10-19	2010-11-27	Эмджен Инк.	Angiopoietin-2-specific coupling agents

2005
- 2005-10-19 RU RU2007118670/13A patent/RU2404992C2/en not_active IP Right Cessation
- 2005-10-19 MX MX2007004247A patent/MX2007004247A/en active IP Right Grant
- 2005-10-19 SG SG200907008-7A patent/SG156668A1/en unknown
- 2005-10-19 EA EA200700876A patent/EA011866B1/en not_active IP Right Cessation
- 2005-10-19 CN CN200580043569.5A patent/CN101495513B/en not_active Expired - Fee Related
- 2005-10-19 BR BRPI0518209-3A patent/BRPI0518209A/en not_active IP Right Cessation
- 2005-10-19 JP JP2007538066A patent/JP2008520188A/en active Pending
2007
- 2007-03-28 IL IL182279A patent/IL182279A0/en unknown
- 2007-05-11 MA MA29892A patent/MA29015B1/en unknown
- 2007-05-18 ZA ZA200704020A patent/ZA200704020B/en unknown
2010
- 2010-08-05 RU RU2010132956/10A patent/RU2010132956A/en not_active Application Discontinuation
2011
- 2011-03-30 JP JP2011075243A patent/JP2011207882A/en not_active Withdrawn

Also Published As

Publication number	Publication date
EA011866B1 (en)	2009-06-30
CN101495513A (en)	2009-07-29
ZA200704020B (en)	2008-06-25
SG156668A1 (en)	2009-11-26
BRPI0518209A (en)	2008-11-04
IL182279A0 (en)	2007-07-24
RU2404992C2 (en)	2010-11-27
MX2007004247A (en)	2007-06-12
JP2008520188A (en)	2008-06-19
EA200700876A1 (en)	2007-10-26
JP2011207882A (en)	2011-10-20
CN101495513B (en)	2014-08-06
RU2007118670A (en)	2008-12-27
RU2010132956A (en)	2012-02-10

Publication	Publication Date	Title
MA29015B1 (en)	2007-11-01	SPECIFIC BINDING AGENTS OF ANGIOPOIETIN-2
NO20041907L (en)	2004-05-10	Angiopoietin-2 specific binding agents
DE602004019159D1 (en)	2009-03-12	throttle body
FR2871145B1 (en)	2006-08-18	DISTRIBUTOR OF APPLICATORS
GB0307671D0 (en)	2003-05-07	Improvements relating to the construction of playing surfaces
DE60134988D1 (en)	2008-09-04	CONNECTABLE ELASTOMER COMPOSITION
FR2875398B1 (en)	2007-07-06	JOINT IMPLANT OF INTERPOSITION
MA28812B1 (en)	2007-08-01	COMBINATIONS OF EPOTHILONE
FR2880793B1 (en)	2007-12-14	SHOULDER PROSTHESIS
FR2879635B1 (en)	2008-09-26	OSSATURE CONNECTOR
GB0510474D0 (en)	2005-06-29	Q's vaginometer
DE602004017295D1 (en)	2008-12-04	THROTTLE BODY
ZA200709553B (en)	2009-03-25	Player's outfit
IL190045A0 (en)	2008-12-29	Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents
DK1960510T3 (en)	2014-05-26	AMMONIA-SPECIFIC 5'-XMP AMINASEMUTANT
FR2879109B1 (en)	2007-04-27	ABSORBENT COMPOSITION OF HUMIDITY
GB2409587B (en)	2006-01-11	'Kwicap'
FR2853380B1 (en)	2005-05-13	ELASTIC ARTICULATION
FR2878004B3 (en)	2006-09-29	ANGLE BRIDGE
ITSV20040008A1 (en)	2004-05-18	DOCTOR "G"
ITMN20040010A1 (en)	2004-07-09	PORTAMENU '
UA9704S (en)	2004-12-15	CHILDREN'S SLEDGES
ES1054827Y (en)	2003-12-16	"GASOIL PURIFIER"
FR2862726B1 (en)	2006-02-10	LIAISON BODY
GB0406046D0 (en)	2004-04-21	Affinity purification of protein